Cadence Pharmaceuticals™

Investor Relations

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.

Recent Releases

Aug 27, 2008
Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference

Aug 7, 2008
Cadence Pharmaceuticals Reports Second Quarter 2008 Financial Results and Provides Overview of Clinical Programs

Events

Sep 4, 2008
2008 NewsMakers In the Biotech Industry Conference

Aug 12, 2008
Canaccord Adams' 28th Annual Global Growth Conference

more »
Print page Print
Email page Email


Stock Quote
CADX - (NASD)
$9.89   + 0.07
Aug 28, 2008
12:50 PM ET

Quotes delayed at
least 20 minutes.
Information provided
by TurboFeed.

©2005 Cadence™ Pharmaceuticals. All rights reserved. No portion of cadencepharm.com may be duplicated, redistributed or manipulated in any form. CADENCE and OMIGARD are trademarks of Cadence Pharmaceuticals, Inc.